Related references
Note: Only part of the references are listed.Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells
Baoan Chen
International Journal of Nanomedicine (2010)
Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure
Susanna Miettinen et al.
ANTI-CANCER DRUGS (2009)
Reversal of drug resistance in ovarian cancer: Where do we go from here?
Stan B. Kaye
JOURNAL OF CLINICAL ONCOLOGY (2008)
Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies
M. Mimeault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery
Lilian E. van Vlerken et al.
PHARMACEUTICAL RESEARCH (2007)
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Cindy L. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin/apolipoprotein J
Magda Lourda et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Nonfouling characteristics of dextran-containing surfaces
Surangkhana Martwiset et al.
LANGMUIR (2006)
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Alexander J. Chou et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Enhanced anti proliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
Sanjeeb K. Sahoo et al.
MOLECULAR PHARMACEUTICS (2005)
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: Final induction results of cancer and leukemia group B study 9621
JE Kolitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs
AN Lukyanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
PEGylated nanoparticles for biological and pharmaceutical applications
H Otsuka et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Kinetics of surface-initiated atom transfer radical polymerization
JB Kim et al.
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY (2003)
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation
A El-Osta et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: An EORTC-HOVON randomized phase III study (06914)
P Sonneveld et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
R Krishna et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Share Paper
